# AM-101 in the Treatment of Post-Acute Tinnitus 1

> **NCT01934010** · PHASE3 · COMPLETED · sponsor: **Auris Medical, Inc.** · enrollment: 260 (actual)

## Conditions studied

- Tinnitus

## Interventions

- **DRUG:** AM-101

## Key facts

- **NCT ID:** NCT01934010
- **Lead sponsor:** Auris Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2018-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01934010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01934010, "AM-101 in the Treatment of Post-Acute Tinnitus 1". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01934010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*